Medikra Inc. (MDKR)

Medikra Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Revenue	0.02	0.03	0.07
Revenue Growth (YoY)	-	-61.72%	-
Cost of Revenue	-	0.01	0.02
Gross Profit	0.01	0.02	0.05
Selling, General & Admin	-	0.29	0.12
Research & Development	-	0.1	0
Operating Expenses	-	0.39	0.13
Operating Income	-0.87	-0.37	-0.08
Interest Expense (Income)	0.01	0.01	0.02
Other Expense (Income)	-0.1	-0.1	-0.12
Pretax Income	-0.78	-0.28	0.02
Net Income	-0.78	-0.28	0.02
Free Cash Flow	-0.84	-0.24	-0.17
Gross Margin	79.77%	78.76%	70.50%
Operating Margin	-5420.65%	-1406.56%	-116.05%
Profit Margin	-4822.47%	-1066.66%	27.53%
Free Cash Flow Margin	-5225.97%	-925.36%	-244.86%
EBITDA	-0.75	-0.25	0.05
EBITDA Margin	-4662.29%	-971.81%	78.80%
Depreciation & Amortization	0.02	0.02	0.02
EBIT	-0.77	-0.27	0.04
EBIT Margin	-4774.60%	-1040.88%	54.53%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).